Motor Function Measure: validation of a short form (MFM-20) for young children with neuromuscular diseases
Capucine de Lattre, Christine Payan, Carole Vuillerot, Pascal Rippert, Denis de Castro, Carole Bérard, Isabelle Poirot and the MFM-20 Study Group.
Arch Phys Med Rehabil. 2013. 94 : 2218-26.
Validation of MFM version useful in neuromuscular children under 7 years old, the MFM-20. MFM-32 was completed on 194 healthy children aged 2-7 years. Twenty items of the MFM-32 were successfully completed by these children and were used to constitute the MFM-20. 88 children with a neuromuscular disease were rated by the MFM by a trained medical professional. Principal component analysis of the MFM-20 confirmed the 3 functional domains of the MFM (D1, D2 and D3). Inter- and intra-rater reliability of the 3 sub-scores and total score were high (ICC > 0.90) and discriminant validity was good. The MFM-20 can be used as an outcome measure for assessment of motor function in young children with a neuromuscular disease.
Keywords: Neuromuscular disease, Motor function, Disability evaluation, Rehabilitation, Metrology
Articles dans les revues scientifiques
Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC. Arq Neuropsiquiatr. 2012. 70(3): 191-5. Description of the evolution of the motor function of 33 DMD patients (27 ambulant and 6 non ambulant at inclusion) treated with steroids during 18 month assessed...
Quantitative MRI can detect subclinical disease progression in muscular dystrophy.
Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D. J Neurol. 2012. 259(8): 1648-54. The aim of this study was to compare different methods of quantitative and semiquantitative MRI in order to validate clinical parameters for the follow-u of...
The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder.
Jansen M, De Jong M, Coes HM, Eggermont F, Van Alfen N, De Groot IJ. Muscle Nerve. 2012. 46(4): 520-3. Development of the "assisted 6-minute cycling" aiming to assess DMD patients' endurance.MFM is use as a gold standard.PubMed linkKeywords: Assisted 6-minute cycling...
Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy
Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D. J Neurol 2011. 258: 1333–1340. Oculopharyngeal muscular dystrophy (OPMD) is a progressive skeletal muscle dystrophy characterized by ptosis, dysphagia, and...
Impaired Mandibular Function in Spinal Muscular Atrophy Type II: Need for Early Recognition
van Bruggen HW, van den Engel-Hoek L, van der Pol WL, de Wijer A, de Groot IJ, Steenks MH. J Child Neurol. Nov 2011. 26: 1392 - 1396. The aim of the study is to assess mandibular function in young patients with spinal muscular atrophy type II. The mandibular function...
Idebenone for the treatment of Duchenne muscular dystrophy (Protocol)
Geng J, Dong J, Jiang K, Shen L, Wu T, Ni H, Shi LL, Wang G, Wu H. The Cochrane Library 2011. Description of a protocol aiming at assessing efficacy of ibedenone on muscle strength, muscle function, lung function, cardiac function and quality of life for patients with...